Science & Technology
(U20)
INTERNATIONAL SOCIETY FOR CNS DRUG DEVELOPMENT INC
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$338K
Total Revenue
$366K
Total Expenses
$701K
Net Assets
3
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
74.8%
Fundraising Efficiency
0.0%
Operating Reserve
22.95x
Liability-to-Asset
0.3%
Revenue Diversification
65.2%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $338K | $366K | $701K | 74.8% | 3 |
| 2022 | $265K | $325K | N/A | — | 3 |
| 2021 | $237K | $218K | N/A | — | 1 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.